Michael F. Burgess

Insider Reports History

Entity
Individual
Location
C/O Synlogic, Inc., 301 Binney Street, Suite 402, Camridge, MA
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael F. Burgess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Head of Research & Development Common Stock 49.6K $2.06M $41.53 Jul 18, 2022 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 30K Jun 22, 2023 Direct
Turnstone Biologics Corp. Interim Chief Medical Officer, Director Employee Stock Option (Right to Buy) 11.5K Oct 16, 2023 Direct

Insider Reports Filed by Michael F. Burgess

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSBX Turnstone Biologics Corp. Oct 16, 2023 1 $0 4 Oct 17, 2023 Interim Chief Medical Officer, Director
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Interim Chief Medical Officer, Director
SYBX SYNLOGIC, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
SWTX SpringWorks Therapeutics, Inc. Jul 18, 2022 1 -$88.3K 4 Jul 20, 2022 Head of Research & Development
SYBX SYNLOGIC, INC. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
SWTX SpringWorks Therapeutics, Inc. Jun 1, 2022 2 -$52.4K 4 Jul 5, 2022 Head of Research & Development
SWTX SpringWorks Therapeutics, Inc. Jan 6, 2022 2 $0 4 Jan 10, 2022 Head of Research & Development
SYBX SYNLOGIC, INC. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
SWTX SpringWorks Therapeutics, Inc. Jun 1, 2021 2 $0 4 Jun 1, 2021 Head of Research & Development
SWTX SpringWorks Therapeutics, Inc. May 10, 2021 0 $0 3 May 10, 2021 Head of Research & Development